MBX
MBX Biosciences, Inc.
57.72
+1.39 (+2.47%)
52w low 23.07
72.64 high
69.9% of range
Financial Analysis
| Ratio | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on Equity | -8.9% | -5.6% | -6.0% | -5.4% | -9.1% | |
| Return on Assets | -8.4% | -5.4% | -5.7% | -5.2% | -8.5% | |
| Return on Inv Capital | -7.9% | -4.9% | -5.5% | -4.9% | -7.9% | |
| Liquidity | ||||||
| Current Ratio | 19.50x | 32.95x | 24.62x | 30.79x | 18.08x | |
| Quick Ratio | 19.50x | 32.95x | 24.62x | 30.79x | 18.08x | |
| Cash Ratio | 3.38x | 18.50x | 4.86x | 3.10x | 2.29x | |
| Leverage | ||||||
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | |
| Equity Multiplier | 1.06x | 1.03x | 1.04x | 1.03x | 1.06x | |
| Efficiency | ||||||
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | |
| Op CF / Net Income | 0.90x | 1.00x | 0.83x | 0.86x | 0.61x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--